Status:
COMPLETED
Safety of the PET-511BTM Transesophageal Transducer
Lead Sponsor:
Toshiba America Medical Systems, Inc.
Conditions:
Patient Requiring TEE Procedure by Their Physician
Eligibility:
All Genders
20-85 years
Brief Summary
The purpose of this study is to demonstrate the safety of the redesigned transesophageal echocardiogram (TEE) transducer as it is inserted and transitioned into the esophagus through the mouth.
Detailed Description
The PET-511BTM is a multiplane transesophageal transducer designed for use with Toshiba Diagnostic Ultrasound Systems for the visualization of the heart (and other organs) as a real-time ultrasound im...
Eligibility Criteria
Inclusion
- Male and female patients between the ages of 20 and 80
- Informed consent understood and signed
- Compliance with post-treatment follow-up protocol requirements
Exclusion
- None
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00997568
Start Date
October 1 2009
Last Update
August 20 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Scripps Health
La Jolla, California, United States, 92037
2
The Christ Hospital
Cincinnati, Ohio, United States, 45219